Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AZITHROMYCIN Cause Therapy partial responder? 27 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Therapy partial responder have been filed in association with AZITHROMYCIN (AZITHROMYCIN). This represents 0.2% of all adverse event reports for AZITHROMYCIN.

27
Reports of Therapy partial responder with AZITHROMYCIN
0.2%
of all AZITHROMYCIN reports
1
Deaths
7
Hospitalizations

How Dangerous Is Therapy partial responder From AZITHROMYCIN?

Of the 27 reports, 1 (3.7%) resulted in death, 7 (25.9%) required hospitalization, and 4 (14.8%) were considered life-threatening.

Is Therapy partial responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AZITHROMYCIN. However, 27 reports have been filed with the FAERS database.

What Other Side Effects Does AZITHROMYCIN Cause?

Off label use (2,979) Drug ineffective (2,609) Drug hypersensitivity (1,978) Dyspnoea (1,409) Condition aggravated (1,063) Nausea (1,006) Asthma (972) Wheezing (951) Product use in unapproved indication (886) Cough (837)

What Other Drugs Cause Therapy partial responder?

CYCLOPHOSPHAMIDE (1,397) RITUXIMAB (1,219) DEXAMETHASONE (1,199) PREDNISONE (1,176) PEMBROLIZUMAB (1,125) CARBOPLATIN (1,096) DOXORUBICIN (834) METHOTREXATE (775) VINCRISTINE (707) ETOPOSIDE (670)

Which AZITHROMYCIN Alternatives Have Lower Therapy partial responder Risk?

AZITHROMYCIN vs AZITHROMYCIN ANHYDROUS AZITHROMYCIN vs AZITHROMYCIN OR METHOTREXATE AZITHROMYCIN vs AZOSEMIDE AZITHROMYCIN vs AZTREONAM AZITHROMYCIN vs AZTREONAM LYSINE

Related Pages

AZITHROMYCIN Full Profile All Therapy partial responder Reports All Drugs Causing Therapy partial responder AZITHROMYCIN Demographics